CVI Investments, Inc. - 30 Jun 2025 SCHEDULE 13G/A Report for Galmed Pharmaceuticals Ltd. Ordinary Shares, NIS 1.80 par value per share (GLMD)

Filing Manager: CVI Investments, Inc.
Reporting Manager: CVI Investments, Inc.
Security: Galmed Pharmaceuticals Ltd. Ordinary Shares, NIS 1.80 par value per share
Symbol: GLMD
Shares outstanding: 2.44M shares
Disclosed Ownership: 173K shares
Ownership: 7.1%
Form type: SCHEDULE 13G/A
Filing time: 14 Aug 2025, 14:01:00 UTC
Date of event: 30 Jun 2025
Next filing: 07 Nov 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
CVI Investments, Inc.	7.1%	173K	0	173K	/s/ Sarah Travis	Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc.
Heights Capital Management, Inc.	7.1%	173K	0	173K	/s/ Sarah Travis	Sarah Travis, Assistant General Counsel and Assistant Secretary